Song Cao1,2,3, Daniel W Fisher3,4, Guadalupe Rodriguez3, Tian Yu2, Hongxin Dong5. 1. Department of Pain Medicine, Affiliated Hospital of Zunyi Medical University, 149 Dalian Street, Zunyi, 563000, Guizhou, China. 2. Guizhou Key Lab of Anesthesia and Organ Protection, Affiliated Hospital of Zunyi Medical University, 6 West Xuefu Street, Zunyi, 563002, Guizhou, China. 3. Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, 303 East Chicago Avenue, Chicago, IL, 60611, USA. 4. Department of Psychiatry and Behavioral Sciences, University of Washington Medical Center, 1959 NE Pacific St, Seattle, WA, 98195, USA. 5. Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, 303 East Chicago Avenue, Chicago, IL, 60611, USA. h-dong@northwestern.edu.
Abstract
BACKGROUND: The role of microglia in Alzheimer's disease (AD) pathogenesis is becoming increasingly important, as activation of these cell types likely contributes to both pathological and protective processes associated with all phases of the disease. During early AD pathogenesis, one of the first areas of degeneration is the locus coeruleus (LC), which provides broad innervation of the central nervous system and facilitates norepinephrine (NE) transmission. Though the LC-NE is likely to influence microglial dynamics, it is unclear how these systems change with AD compared to otherwise healthy aging. METHODS: In this study, we evaluated the dynamic changes of neuroinflammation and neurodegeneration in the LC-NE system in the brain and spinal cord of APP/PS1 mice and aged WT mice using immunofluorescence and ELISA. RESULTS: Our results demonstrated increased expression of inflammatory cytokines and microglial activation observed in the cortex, hippocampus, and spinal cord of APP/PS1 compared to WT mice. LC-NE neuron and fiber loss as well as reduced norepinephrine transporter (NET) expression was more evident in APP/PS1 mice, although NE levels were similar between 12-month-old APP/PS1 and WT mice. Notably, the degree of microglial activation, LC-NE nerve fiber loss, and NET reduction in the brain and spinal cord were more severe in 12-month-old APP/PS1 compared to 12- and 24-month-old WT mice. CONCLUSION: These results suggest that elevated neuroinflammation and microglial activation in the brain and spinal cord of APP/PS1 mice correlate with significant degeneration of the LC-NE system.
BACKGROUND: The role of microglia in Alzheimer's disease (AD) pathogenesis is becoming increasingly important, as activation of these cell types likely contributes to both pathological and protective processes associated with all phases of the disease. During early AD pathogenesis, one of the first areas of degeneration is the locus coeruleus (LC), which provides broad innervation of the central nervous system and facilitates norepinephrine (NE) transmission. Though the LC-NE is likely to influence microglial dynamics, it is unclear how these systems change with AD compared to otherwise healthy aging. METHODS: In this study, we evaluated the dynamic changes of neuroinflammation and neurodegeneration in the LC-NE system in the brain and spinal cord of APP/PS1mice and aged WT mice using immunofluorescence and ELISA. RESULTS: Our results demonstrated increased expression of inflammatory cytokines and microglial activation observed in the cortex, hippocampus, and spinal cord of APP/PS1 compared to WT mice. LC-NE neuron and fiber loss as well as reduced norepinephrine transporter (NET) expression was more evident in APP/PS1mice, although NE levels were similar between 12-month-old APP/PS1 and WT mice. Notably, the degree of microglial activation, LC-NE nerve fiber loss, and NET reduction in the brain and spinal cord were more severe in 12-month-old APP/PS1 compared to 12- and 24-month-old WT mice. CONCLUSION: These results suggest that elevated neuroinflammation and microglial activation in the brain and spinal cord of APP/PS1mice correlate with significant degeneration of the LC-NE system.
Authors: Saikat Chakraborty; Jack C Lennon; Sridhar A Malkaram; Yan Zeng; Daniel W Fisher; Hongxin Dong Journal: Neurosci Lett Date: 2019-04-01 Impact factor: 3.046
Authors: J Wegiel; K C Wang; H Imaki; R Rubenstein; A Wronska; M Osuchowski; W J Lipinski; L C Walker; H LeVine Journal: Neurobiol Aging Date: 2001 Jan-Feb Impact factor: 4.673
Authors: Carmen Venegas; Sathish Kumar; Bernardo S Franklin; Tobias Dierkes; Rebecca Brinkschulte; Dario Tejera; Ana Vieira-Saecker; Stephanie Schwartz; Francesco Santarelli; Markus P Kummer; Angelika Griep; Ellen Gelpi; Michael Beilharz; Dietmar Riedel; Douglas T Golenbock; Matthias Geyer; Jochen Walter; Eicke Latz; Michael T Heneka Journal: Nature Date: 2017-12-20 Impact factor: 49.962
Authors: Julia Marschallinger; Tal Iram; Macy Zardeneta; Song E Lee; Benoit Lehallier; Michael S Haney; John V Pluvinage; Vidhu Mathur; Oliver Hahn; David W Morgens; Justin Kim; Julia Tevini; Thomas K Felder; Heimo Wolinski; Carolyn R Bertozzi; Michael C Bassik; Ludwig Aigner; Tony Wyss-Coray Journal: Nat Neurosci Date: 2020-01-20 Impact factor: 24.884
Authors: Michael A Kelberman; Claire R Anderson; Eli Chlan; Jacki M Rorabaugh; Katharine E McCann; David Weinshenker Journal: J Alzheimers Dis Date: 2022 Impact factor: 4.472
Authors: Irene L Gutiérrez; Cinzia Dello Russo; Fabiana Novellino; Javier R Caso; Borja García-Bueno; Juan C Leza; José L M Madrigal Journal: Int J Mol Sci Date: 2022-05-30 Impact factor: 6.208